Teligent, Inc. - stock earnings
Stock symbol TLGT is outdated, potentially delisted? Maybe it is available on other exchange?
TLGT Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2021Q2 | -12.9 million USD | 10.4 million USD |
2021Q1 | 2.2 million USD | 11.6 million USD |
2020Q4 | -80.3 million USD | 9.9 million USD |
2020Q3 | -510000 USD | 14.3 million USD |
TLGT Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2020 | -122.0 million USD | 45.3 million USD |
2019 | -25.1 million USD | 65.9 million USD |
2018 | -36.3 million USD | 65.9 million USD |
2017 | -15.2 million USD | 60.2 million USD |
TLGT
Price: $0.17
52 week price:
Earnings Per Share: -0.39 USD
P/E Ratio: -0.05
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 72.2 million
Ebitda: -4.2 millionMarket Capitalization: 16.1 million